nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.494	1	CbGbCtD
Ofloxacin—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0265	0.141	CbGpPWpGaD
Ofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0218	0.115	CbGpPWpGaD
Ofloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0164	0.0867	CbGpPWpGaD
Ofloxacin—Airway obstruction NOS—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0552	CcSEcCtD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0124	0.0655	CbGpPWpGaD
Ofloxacin—Obstructive airways disorder—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0399	CcSEcCtD
Ofloxacin—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.00729	0.0259	CcSEcCtD
Ofloxacin—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0217	CcSEcCtD
Ofloxacin—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.00552	0.0196	CcSEcCtD
Ofloxacin—CYP1A2—urine—nephrolithiasis	0.00524	0.146	CbGeAlD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00436	0.0231	CbGpPWpGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00406	0.0215	CbGpPWpGaD
Ofloxacin—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0143	CcSEcCtD
Ofloxacin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.00397	0.0141	CcSEcCtD
Ofloxacin—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00377	0.0134	CcSEcCtD
Ofloxacin—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0132	CcSEcCtD
Ofloxacin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0122	CcSEcCtD
Ofloxacin—SLC22A6—nephron tubule—nephrolithiasis	0.00344	0.0956	CbGeAlD
Ofloxacin—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00333	0.0118	CcSEcCtD
Ofloxacin—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00333	0.0118	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00328	0.0174	CbGpPWpGaD
Ofloxacin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00315	0.0112	CcSEcCtD
Ofloxacin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00315	0.0112	CcSEcCtD
Ofloxacin—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00307	0.0109	CcSEcCtD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00305	0.0161	CbGpPWpGaD
Ofloxacin—SLC22A6—cortex of kidney—nephrolithiasis	0.00295	0.0818	CbGeAlD
Ofloxacin—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00294	0.0105	CcSEcCtD
Ofloxacin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00288	0.0102	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00286	0.0152	CbGpPWpGaD
Ofloxacin—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00282	0.01	CcSEcCtD
Ofloxacin—Gout—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00971	CcSEcCtD
Ofloxacin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00946	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00262	0.0139	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00262	0.0139	CbGpPWpGaD
Ofloxacin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00929	CcSEcCtD
Ofloxacin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00923	CcSEcCtD
Ofloxacin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00906	CcSEcCtD
Ofloxacin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00891	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00248	0.0131	CbGpPWpGaD
Ofloxacin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00856	CcSEcCtD
Ofloxacin—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00851	CcSEcCtD
Ofloxacin—SLC22A4—nephron tubule—nephrolithiasis	0.00235	0.0654	CbGeAlD
Ofloxacin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00233	0.00828	CcSEcCtD
Ofloxacin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0082	CcSEcCtD
Ofloxacin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0082	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0023	0.0122	CbGpPWpGaD
Ofloxacin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00807	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00215	0.0114	CbGpPWpGaD
Ofloxacin—SLC22A4—renal system—nephrolithiasis	0.00214	0.0594	CbGeAlD
Ofloxacin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00214	0.0076	CcSEcCtD
Ofloxacin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00756	CcSEcCtD
Ofloxacin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00749	CcSEcCtD
Ofloxacin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00749	CcSEcCtD
Ofloxacin—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00746	CcSEcCtD
Ofloxacin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00209	0.00742	CcSEcCtD
Ofloxacin—SLC22A4—kidney—nephrolithiasis	0.00207	0.0574	CbGeAlD
Ofloxacin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00736	CcSEcCtD
Ofloxacin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00729	CcSEcCtD
Ofloxacin—SLC22A4—cortex of kidney—nephrolithiasis	0.00201	0.056	CbGeAlD
Ofloxacin—ABCC2—nephron tubule—nephrolithiasis	0.00201	0.0558	CbGeAlD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00198	0.0105	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00198	0.0105	CbGpPWpGaD
Ofloxacin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00703	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00197	0.0104	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00197	0.0104	CbGpPWpGaD
Ofloxacin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00697	CcSEcCtD
Ofloxacin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00697	CcSEcCtD
Ofloxacin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00694	CcSEcCtD
Ofloxacin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00195	0.00694	CcSEcCtD
Ofloxacin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00691	CcSEcCtD
Ofloxacin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00691	CcSEcCtD
Ofloxacin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00683	CcSEcCtD
Ofloxacin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0019	0.00677	CcSEcCtD
Ofloxacin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00661	CcSEcCtD
Ofloxacin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00658	CcSEcCtD
Ofloxacin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00658	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00184	0.00976	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00184	0.00976	CbGpPWpGaD
Ofloxacin—ABCC2—renal system—nephrolithiasis	0.00183	0.0508	CbGeAlD
Ofloxacin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00648	CcSEcCtD
Ofloxacin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00648	CcSEcCtD
Ofloxacin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00635	CcSEcCtD
Ofloxacin—ABCC2—kidney—nephrolithiasis	0.00177	0.0491	CbGeAlD
Ofloxacin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00623	CcSEcCtD
Ofloxacin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00619	CcSEcCtD
Ofloxacin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00616	CcSEcCtD
Ofloxacin—ABCC2—cortex of kidney—nephrolithiasis	0.00172	0.0478	CbGeAlD
Ofloxacin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00603	CcSEcCtD
Ofloxacin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00601	CcSEcCtD
Ofloxacin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00599	CcSEcCtD
Ofloxacin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00595	CcSEcCtD
Ofloxacin—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00593	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00593	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00164	0.0087	CbGpPWpGaD
Ofloxacin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00164	0.00582	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00163	0.00864	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00163	0.00864	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00162	0.0086	CbGpPWpGaD
Ofloxacin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00573	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00161	0.00851	CbGpPWpGaD
Ofloxacin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0016	0.00569	CcSEcCtD
Ofloxacin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00558	CcSEcCtD
Ofloxacin—SLC22A5—nephron tubule—nephrolithiasis	0.00156	0.0433	CbGeAlD
Ofloxacin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00554	CcSEcCtD
Ofloxacin—ABCC1—cortex of kidney—nephrolithiasis	0.00152	0.0421	CbGeAlD
Ofloxacin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00532	CcSEcCtD
Ofloxacin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00532	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00149	0.00789	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00149	0.00789	CbGpPWpGaD
Ofloxacin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00529	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00148	0.00786	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00148	0.00786	CbGpPWpGaD
Ofloxacin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00525	CcSEcCtD
Ofloxacin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00147	0.00524	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00519	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00145	0.0077	CbGpPWpGaD
Ofloxacin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00144	0.00513	CcSEcCtD
Ofloxacin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00143	0.0051	CcSEcCtD
Ofloxacin—SLC22A5—renal system—nephrolithiasis	0.00142	0.0393	CbGeAlD
Ofloxacin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00141	0.00503	CcSEcCtD
Ofloxacin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00141	0.005	CcSEcCtD
Ofloxacin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00498	CcSEcCtD
Ofloxacin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00497	CcSEcCtD
Ofloxacin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00497	CcSEcCtD
Ofloxacin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00494	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00139	0.00734	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00139	0.00734	CbGpPWpGaD
Ofloxacin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00493	CcSEcCtD
Ofloxacin—SLC22A5—kidney—nephrolithiasis	0.00137	0.038	CbGeAlD
Ofloxacin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00136	0.00483	CcSEcCtD
Ofloxacin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00134	0.00478	CcSEcCtD
Ofloxacin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00134	0.00476	CcSEcCtD
Ofloxacin—SLC22A5—cortex of kidney—nephrolithiasis	0.00133	0.037	CbGeAlD
Ofloxacin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00133	0.00473	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00133	0.00704	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00133	0.00704	CbGpPWpGaD
Ofloxacin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0013	0.00463	CcSEcCtD
Ofloxacin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00456	CcSEcCtD
Ofloxacin—CYP1A2—renal system—nephrolithiasis	0.00128	0.0356	CbGeAlD
Ofloxacin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00455	CcSEcCtD
Ofloxacin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00453	CcSEcCtD
Ofloxacin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00452	CcSEcCtD
Ofloxacin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00126	0.00448	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00124	0.00654	CbGpPWpGaD
Ofloxacin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00439	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00123	0.00649	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00123	0.00649	CbGpPWpGaD
Ofloxacin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0043	CcSEcCtD
Ofloxacin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00424	CcSEcCtD
Ofloxacin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00422	CcSEcCtD
Ofloxacin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00407	CcSEcCtD
Ofloxacin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00113	0.00402	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00113	0.00596	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00113	0.00596	CbGpPWpGaD
Ofloxacin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00111	0.00396	CcSEcCtD
Ofloxacin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0039	CcSEcCtD
Ofloxacin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00389	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00109	0.00579	CbGpPWpGaD
Ofloxacin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00109	0.00388	CcSEcCtD
Ofloxacin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00385	CcSEcCtD
Ofloxacin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00108	0.00383	CcSEcCtD
Ofloxacin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00381	CcSEcCtD
Ofloxacin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00105	0.00373	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00105	0.00554	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00105	0.00554	CbGpPWpGaD
Ofloxacin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00104	0.00371	CcSEcCtD
Ofloxacin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00368	CcSEcCtD
Ofloxacin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00366	CcSEcCtD
Ofloxacin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00364	CcSEcCtD
Ofloxacin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00362	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00101	0.00534	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00101	0.00534	CbGpPWpGaD
Ofloxacin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.001	0.00357	CcSEcCtD
Ofloxacin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.001	0.00356	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000999	0.00529	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000999	0.00529	CbGpPWpGaD
Ofloxacin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000999	0.00355	CcSEcCtD
Ofloxacin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000997	0.00355	CcSEcCtD
Ofloxacin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000984	0.0035	CcSEcCtD
Ofloxacin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000979	0.00348	CcSEcCtD
Ofloxacin—Cough—Hydrochlorothiazide—nephrolithiasis	0.000972	0.00346	CcSEcCtD
Ofloxacin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000948	0.00337	CcSEcCtD
Ofloxacin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000948	0.00337	CcSEcCtD
Ofloxacin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000948	0.00337	CcSEcCtD
Ofloxacin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000945	0.00336	CcSEcCtD
Ofloxacin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000937	0.00333	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000937	0.00496	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000937	0.00496	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000932	0.00494	CbGpPWpGaD
Ofloxacin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000928	0.0033	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000925	0.0049	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000925	0.0049	CbGpPWpGaD
Ofloxacin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000917	0.00326	CcSEcCtD
Ofloxacin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000909	0.00323	CcSEcCtD
Ofloxacin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000909	0.00323	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000905	0.00479	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000896	0.00475	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000896	0.00475	CbGpPWpGaD
Ofloxacin—Shock—Hydrochlorothiazide—nephrolithiasis	0.000894	0.00318	CcSEcCtD
Ofloxacin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00089	0.00317	CcSEcCtD
Ofloxacin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000887	0.00316	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000886	0.00469	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000886	0.00469	CbGpPWpGaD
Ofloxacin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000879	0.00313	CcSEcCtD
Ofloxacin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000867	0.00308	CcSEcCtD
Ofloxacin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00085	0.00302	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000835	0.00442	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000835	0.00442	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000828	0.00295	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000825	0.00437	CbGpPWpGaD
Ofloxacin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000822	0.00293	CcSEcCtD
Ofloxacin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000816	0.0029	CcSEcCtD
Ofloxacin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000811	0.00288	CcSEcCtD
Ofloxacin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000808	0.00288	CcSEcCtD
Ofloxacin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0008	0.00285	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000799	0.00423	CbGpPWpGaD
Ofloxacin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00079	0.00281	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00079	0.00418	CbGpPWpGaD
Ofloxacin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000784	0.00279	CcSEcCtD
Ofloxacin—Pain—Hydrochlorothiazide—nephrolithiasis	0.000777	0.00277	CcSEcCtD
Ofloxacin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000777	0.00277	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000757	0.00401	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000757	0.00401	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000754	0.00399	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000754	0.00399	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000749	0.00267	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000743	0.00264	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000731	0.00387	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000731	0.00387	CbGpPWpGaD
Ofloxacin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000722	0.00257	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000722	0.00382	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000722	0.00382	CbGpPWpGaD
Ofloxacin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000719	0.00256	CcSEcCtD
Ofloxacin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000719	0.00256	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000704	0.00373	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000704	0.00373	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00067	0.00238	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000668	0.00354	CbGpPWpGaD
Ofloxacin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000652	0.00232	CcSEcCtD
Ofloxacin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000643	0.00229	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000628	0.00332	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000628	0.00332	CbGpPWpGaD
Ofloxacin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000622	0.00221	CcSEcCtD
Ofloxacin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000601	0.00214	CcSEcCtD
Ofloxacin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000578	0.00206	CcSEcCtD
Ofloxacin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000573	0.00204	CcSEcCtD
Ofloxacin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000573	0.00204	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000572	0.00303	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000572	0.00303	CbGpPWpGaD
Ofloxacin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00057	0.00203	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000554	0.00293	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000554	0.00293	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000547	0.0029	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000547	0.0029	CbGpPWpGaD
Ofloxacin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00054	0.00192	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000532	0.00281	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000532	0.00281	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000529	0.0028	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000515	0.00273	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000515	0.00273	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000509	0.00269	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000509	0.00269	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000502	0.00266	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000474	0.00251	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000474	0.00251	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000459	0.00243	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000459	0.00243	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000454	0.0024	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000454	0.0024	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000379	0.00201	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000367	0.00194	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000363	0.00192	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.000314	0.00167	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC26A1—nephrolithiasis	0.000285	0.00151	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AGXT—nephrolithiasis	0.00028	0.00148	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.000254	0.00134	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APRT—nephrolithiasis	0.000238	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.000238	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—AQP1—nephrolithiasis	0.00017	0.000899	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CHRM3—nephrolithiasis	0.000154	0.000813	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000119	0.000632	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000106	0.000564	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APRT—nephrolithiasis	9.05e-05	0.000479	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	9.05e-05	0.000479	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—AQP1—nephrolithiasis	6.45e-05	0.000342	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CHRM3—nephrolithiasis	5.83e-05	0.000309	CbGpPWpGaD
